Arvee Laboratories (India) Ltd. (NSE:ARVEE)
India
· Delayed Price · Currency is INR 158.00
+4.84 (3.16%)
Mar 10, 2026, 2:37 PM IST
NSE:ARVEE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 271.6 | 384.87 | 303.45 | 613.47 | 399.65 | 473.75 | Upgrade
|
| Revenue Growth (YoY) | -28.87% | 26.83% | -50.53% | 53.50% | -15.64% | 4.31% | Upgrade
|
| Cost of Revenue | 106.54 | 206.85 | 147.02 | 394.48 | 224.4 | 295.02 | Upgrade
|
| Gross Profit | 165.06 | 178.02 | 156.43 | 218.99 | 175.25 | 178.74 | Upgrade
|
| Selling, General & Admin | 71.24 | 70.21 | 59.52 | 61.67 | 57.08 | 55.57 | Upgrade
|
| Other Operating Expenses | 70.63 | 71.69 | 67.54 | 84.51 | 65.02 | 62.48 | Upgrade
|
| Operating Expenses | 153.55 | 153.39 | 142.04 | 166.97 | 145.31 | 142.11 | Upgrade
|
| Operating Income | 11.51 | 24.62 | 14.39 | 52.02 | 29.94 | 36.62 | Upgrade
|
| Interest Expense | -1.25 | -1.51 | -1.88 | -2.86 | -3.15 | -4.92 | Upgrade
|
| Interest & Investment Income | 4.03 | 4.03 | 3.58 | 2.01 | 2.65 | 2.82 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.14 | 1.14 | 1.48 | 11.35 | 3.63 | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.91 | 0.08 | -0.96 | -0.47 | -0.77 | Upgrade
|
| EBT Excluding Unusual Items | 15.37 | 27.38 | 17.65 | 61.56 | 32.6 | 33.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.34 | 1.34 | 0.64 | 0.08 | 1.24 | 2.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | - | 0.01 | - | -0.21 | Upgrade
|
| Pretax Income | 16.7 | 28.71 | 18.3 | 61.65 | 34.49 | 36.41 | Upgrade
|
| Income Tax Expense | -4.05 | 7.24 | 7.78 | 20.46 | 8.75 | 9.64 | Upgrade
|
| Net Income | 20.75 | 21.47 | 10.52 | 41.19 | 25.74 | 26.77 | Upgrade
|
| Net Income to Common | 20.75 | 21.47 | 10.52 | 41.19 | 25.74 | 26.77 | Upgrade
|
| Net Income Growth | -5.42% | 104.15% | -74.46% | 60.04% | -3.87% | 16.46% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 9 | Upgrade
|
| Shares Change (YoY) | 0.27% | - | - | - | 29.28% | -22.65% | Upgrade
|
| EPS (Basic) | 1.88 | 1.95 | 0.95 | 3.74 | 2.34 | 3.14 | Upgrade
|
| EPS (Diluted) | 1.88 | 1.95 | 0.95 | 3.74 | 2.34 | 3.14 | Upgrade
|
| EPS Growth | -5.47% | 105.11% | -74.58% | 60.04% | -25.64% | 50.56% | Upgrade
|
| Free Cash Flow | - | -20.6 | 10.78 | 14.45 | -16.83 | -5.8 | Upgrade
|
| Free Cash Flow Per Share | - | -1.87 | 0.98 | 1.31 | -1.53 | -0.68 | Upgrade
|
| Gross Margin | 60.77% | 46.25% | 51.55% | 35.70% | 43.85% | 37.73% | Upgrade
|
| Operating Margin | 4.24% | 6.40% | 4.74% | 8.48% | 7.49% | 7.73% | Upgrade
|
| Profit Margin | 7.64% | 5.58% | 3.47% | 6.71% | 6.44% | 5.65% | Upgrade
|
| Free Cash Flow Margin | - | -5.35% | 3.55% | 2.35% | -4.21% | -1.22% | Upgrade
|
| EBITDA | 20.43 | 36.11 | 29.29 | 72.73 | 53.05 | 60.6 | Upgrade
|
| EBITDA Margin | 7.52% | 9.38% | 9.65% | 11.86% | 13.28% | 12.79% | Upgrade
|
| D&A For EBITDA | 8.93 | 11.49 | 14.9 | 20.71 | 23.12 | 23.98 | Upgrade
|
| EBIT | 11.51 | 24.62 | 14.39 | 52.02 | 29.94 | 36.62 | Upgrade
|
| EBIT Margin | 4.24% | 6.40% | 4.74% | 8.48% | 7.49% | 7.73% | Upgrade
|
| Effective Tax Rate | - | 25.20% | 42.51% | 33.19% | 25.37% | 26.47% | Upgrade
|
| Revenue as Reported | 279.02 | 391.44 | 309.85 | 626.99 | 407.9 | 479.6 | Upgrade
|
| Advertising Expenses | - | 0.27 | 0.23 | 0.31 | 0.17 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.